Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer

Biomaterials

Volumn 31, Issue 28, 2010, Pages 7355-7363

  Hua, Mu Yi ^a   Yang, Hung Wei ^a   Chuang, Cheng Keng ^b   Tsai, Rung Ywan ^c   Chen, Wen Jauh ^d   Chuang, Kun Lung ^b   Chang, Ying Hsu ^b   Chuang, Heng Chang ^b   Pang, See Tong ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^d NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Drug nanocarriers; Paclitaxel; Polyaniline derivative; Prostate cancer; Taxane drug

Indexed keywords

AQUEOUS SOLUTIONS; BUTYRIC ACIDS; CARBOXYL GROUPS; CELLULAR GROWTH; CYTOTOXIC; HUMAN PROSTATE; HYDROPHOBIC DRUG; MAGNETIC NANOPARTICLES; MAGNETIC TARGETING; NANOCARRIERS; PACLITAXEL; POLYANILINE DERIVATIVES; PROSTATE CANCER CELLS; PROSTATE CANCERS; SIDE EFFECT; TARGETED DRUG DELIVERY; THERAPEUTIC DOSE; THERMAL STABILITY; WATER SOLUBILITIES;

ANILINE; DOPING (ADDITIVES); DRUG DELIVERY; FATTY ACIDS; HYDROCHLORIC ACID; MAGNETIC MATERIALS; NANOMAGNETICS; NANOPARTICLES; POLYANILINE; SODIUM;

DRUG DOSAGE;

MAGNETIC NANOPARTICLE; PACLITAXEL; WATER; ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOPARTICLE;

AQUEOUS SOLUTION; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; HYDROPHOBICITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; THERMOSTABILITY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; MAGNETISM; MALE; METABOLISM; PROSTATIC NEOPLASMS; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETICS; MALE; MOLECULAR STRUCTURE; NANOPARTICLES; PACLITAXEL; PROSTATIC NEOPLASMS;

EID: 77955269725     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.05.061     Document Type: Article

References (48)

1. Grönberg H. Prostate cancer epidemiology. Lancet 2003, 361:859-864.
2. Quinn M., Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002, 90:162-173.
3. Quinn M., Babb P., Quinn M., Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries. BJU Int 2002, 90:174-184.
4. Nakata S., Takahashi H., Ohtake N., Takei T., Yamanaka H. Trends and characteristics in prostate cancer mortality in Japan. Int J Urol 2000, 7:254-257.
5. Mettlin C. Recent developments in the epidemiology of prostate cancer. Eur J Cancer 1997, 33:340-347.
6. Kerr J.F., Searle J. Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch B Cell Pathol 1973, 13:87-102.
7. Sandford N.L., Searle J.W., Kerr J.F. Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation. Pathology 1984, 16:406-410.
8. Tannock L.F., Wit R.D., Berry W.R., Horti J., Pluzanska A., Chi K.N., et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004, 351:1502-1512.
9. Bilensoy E., Gürkaynak O., Ertan M., Sen M., Hincal A.A. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel. J Pharm Sci 2008, 97:1519-1529.
10. Yu J.M., Li Y.J., Qiu L.Y., Jin Y. Self-aggregated nanoparticles of cholesterol-modified glycol chitosan conjugate: preparation, characterization, and preliminary assessment as a new drug delivery carrier. Eur Polym J 2008, 44:555-565.
11. Xiao K., Luo J., Fowler W.L., Li Y., Lee J.S., Xing L., et al. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials 2009, 30:6006-6016.
12. Zhang X., Jackson J.K., Burt H.M. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 1996, 132:195-206.
13. Danhier F., Magotteaux N., Ucakar B., Lecouturier N., Brewster M., Préat V. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Eur J Pharm Biopharm 2009, 73:230-238.
14. Lavasanifar A., Samuel J., Kwon G.S. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002, 54:169-190.
15. Soga O., Nostrum C.F., Fens M., Rijcken C.J.F., Schiffelers R.M., Storm G., et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release 2005, 103:341-353.
16. Zhang X.G., Miao J., Dai Y.Q., Du Y.Z., Yuan H., Hu F.Q. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm 2008, 361:239-244.
17. Lee M.K., Lim S.J., Kim C.K. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007, 28:2137-2146.
18. Hong J., Xu D., Gong P., Yu J., Ma H., Yao S. Covalent-bonded immobilization of enzyme on hydrophilic polymer covering magnetic nanogels. Microporous Mesoporous Mater 2008, 109:470-477.
19. Lee G., Kim J., Lee J.H. Development of magnetically separable polyaniline nanofibers for enzyme immobilization and recovery. Enzym Microb Technol 2008, 42:466-472.
20. Lee D.G., Ponvel K.M., Kim M., Hwang S., Ahn I.S., Lee C.H. Immobilization of lipase on hydrophobic nano-sized magnetite particles. J Mol Catal B Enzym 2009, 57:62-66.
21. Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res 2006, 67:55-60.
22. Horák D., Babi M., Macková H., Bene M.J. Preparation and properties of magnetic nano- and microsized particles for biological and environmental separations. J Sep Sci 2007, 30:1751-1772.
23. Gamarra J.F., Brito G.E.S., Pontuschka W.M., Amaro E., Parma A.H.C., Goya G.F. Biocompatible superparamagnetic iron oxide nanoparticles used for contrast agents: a structural and magnetic study. J Magn Magn Mater 2005, 289:439-441.
24. 4 nanoparticles and their biomedical applications. Biomaterials 2005, 26:729-738.
25. Asmatulu R., Zalich M.A., Claus R.O., Riffle J.S. Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. J Magn Magn Mater 2005, 292:108-119.
26. Ma Y.H., Hsu Y.W., Chang Y.J., Hua M.Y., Chen J.P., Wu T. Intra-arterial application of magnetic nanoparticles for targeted thrombolytic therapy: a rat embolic model. J Magn Magn Mater 2007, 311:342-346.
27. Ma Y.H., Wu S.Y., Wu T., Chang Y.J., Hua M.Y., Chen J.P. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles. Biomaterials 2009, 30:3343-3351.
28. Liberti P.A., Rao C.G., Terstappen W.M.M. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magn Magn Mater 2001, 225:301-307.
29. Sonvico F., Mornet S., Vasseur S., Dubernet C., Jaillard D., Degrouard J., et al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem 2005, 16:1181-1188.
30. Kohler N., Sun C., Wang J., Zhang M. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 2005, 21:8858-8864.
31. Zhang J.L., Srivastava R.S., Misra R.D.K. Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization, and LCST of viable drug-targeting delivery system. Langmuir 2007, 23:6342-6351.
32. Zhang Y., Zhang J. Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells. J Colloid Interface Sci 2005, 283:352-357.
33. Hu F., Li Z., Tu C., Gao M. Preparation of magnetite nanocrystals with surface reactive moieties by one-pot reaction. J Colloid Interface Sci 2007, 311:469-474.
34. Guimard N.K., Gomez N., Schmidt C.E. Conducting polymers in biomedical engineering. Prog Polym Sci 2007, 32:876-921.
35. Wang C.H., Dong Y.Q., Sengothi K., Tan K.L., Kang E.T. In-vivo tissue response to polyaniline. Synth Met 1999, 102:1313-1314.
36. Li M., Guo Y., Wei Y., MacDiarmid A.G., Lelkes P.I. Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications. Biomaterials 2006, 27:2705-2715.
37. Kim H.S., Hobbs H.L., Wang L., Rutten M.J., Wamser C.C. Biocompatible composites of polyaniline nanofibers and collagen. Synth Met 2009, 159:1313-1318.
38. Dispenza C., Leone M., Presti C.L., Librizzi F., Spadaro G., Vetri V. Optical properties of biocompatible polyaniline nano-composites. J Non-Cryst Solids 2006, 352:3835-3840.
39. Fang N., Tan W.J., Leong K.W., Mao H.Q., Chan V. pH responsive adhesion of phospholipid vesicle on poly(acrylic acid) cushion grafted to poly(ethylene terephthalate) surface. Colloid Surf B Biointerfaces 2005, 42:245-252.
40. Martin N., Catalin J., Blachon M.F., Durand A. Assay of paclitaxel (taxol) in plasma and urine by highperformance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998, 709:281-288.
41. Sharma S., Ganesh T., Kingston G.I., Bane S. Promotion of tubulin assembly by poorly soluble taxol analogs. Anal Biochem 2007, 360:56-62.
42. Angelopoulos M., Ray A., MacDiarmid A.G., Epstein A.J. Polyaniline: processability from aqueous solutions and effect of water vapor on conductivity. Synth Met 1987, 21:21-30.
43. 2 nanoparticles with surfactants. Colloids Surf A Physicochem Eng Asp 2009, 348:270-275.
44. 2 agglomerates in electrostatically stabilized aqueous dispersions. Powder Technol 2005, 160:121-126.
45. Guenard D., Gueritte-Voegelein F., Potier P. Taxol and taxotere: Discovery, chemistry, and structure-activity relationships. Acc Chem Res 1993, 26:160-167.
46. Lee D.G., Ponvel K.M., Kim M., Hwang S., Ahn I.S., Lee C.H. Immobilization of lipase on hydrophobic nano-sized magnetite particles. J Mol Catal B Enzym 2009, 57:62-66.
47. Nam H.Y., Kwon S.M., Chung H., Lee S.Y., Kwon S.H., Jeon H., et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release 2009, 135:259-267.
48. Rao S., He L., Chakravarty S., Ojima I., Orr G.A., Horwitz S.B. Characterization of the taxol binding site on the microtubule. J Biol Chem 1999, 274:37990-37994.